ALX Oncology Inc. (ALXO)
NASDAQ: ALXO
· Real-Time Price · USD
0.63
-0.03 (-3.82%)
At close: Aug 15, 2025, 12:50 PM
ALX Oncology Fail-to-Deliver
Total FTD Shares
3.79K
Below Average
FTD / Avg. Volume
0.72%
Low Impact
1-Year Change
13.7%
Positive Trend
FTD Chart
As of Jul 8, 2025,
ALX Oncology Inc. has
3,788
shares failed to deliver, representing 0.72%
of the average daily volume of
526,322
shares. Over the past year, the monthly average FTD is
11,700
shares, with the current level 68% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 08, 2025 | 0.4587 | 3.79K | -78.33% |
| Jun 30, 2025 | 0.4151 | 17.48K | +436.23% |
| May 28, 2025 | 0.4481 | 3.26K | -64.96% |
| Apr 30, 2025 | 0.54 | 9.3K | +23753.85% |
| Mar 31, 2025 | 0.623 | 39 | -99.59% |
| Feb 10, 2025 | 1.04 | 9.47K | +9466.67% |
| Jan 24, 2025 | 1.52 | 99 | -76.37% |
| Dec 27, 2024 | 1.62 | 419 | -78.84% |
| Nov 27, 2024 | 1.51 | 1.98K | +32900.00% |
| Oct 31, 2024 | 1.43 | 6 | -99.89% |
| Sep 20, 2024 | 2.07 | 5.44K | -96.72% |
| Aug 19, 2024 | 2.57 | 165.78K | +3998.37% |
| Jul 18, 2024 | 6.61 | 4.04K | -35.74% |
| Jun 28, 2024 | 6.03 | 6.29K | +601.78% |
| May 30, 2024 | 10.65 | 897 | -63.30% |
| Apr 24, 2024 | 16.22 | 2.44K | -9.75% |
| Mar 26, 2024 | 11.19 | 2.71K | +291.90% |
| Feb 29, 2024 | 14.67 | 691 | -86.99% |
| Jan 31, 2024 | 14.41 | 5.31K | +110.97% |
| Dec 28, 2023 | 15.29 | 2.52K | -4.22% |
| Nov 30, 2023 | 7.84 | 2.63K | +19.02% |
| Oct 30, 2023 | 6.88 | 2.21K | +126.23% |
| Sep 29, 2023 | 4.8 | 976 | -1.71% |
| Aug 10, 2023 | 5.04 | 993 | +375.12% |
| Jul 28, 2023 | 5.94 | 209 | -88.79% |
| Jun 30, 2023 | 7.51 | 1.86K | -60.55% |
| May 31, 2023 | 6.67 | 4.73K | -31.72% |
| Apr 27, 2023 | 5.58 | 6.92K | +1211.17% |
| Mar 24, 2023 | 4.66 | 528 | -77.41% |
| Feb 27, 2023 | 6.68 | 2.34K | +700.34% |
| Jan 30, 2023 | 9.28 | 292 | n/a |